BARD1AG SA
Blood test for cancer detection
Develop a blood test for detection of cancer (such as lung, colon, prostate, leukemia) based on BARD1.
Different aberrant forms of the protein BARD1 (normally a tumor suppressor) are expressed by cancers. They are biomarkers of cancer and correlated with cancer progression. Thus their detection in the blood can be developed towards a screening and diagnostic test.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No Jobs
No videos and documents
Venture Kick
Venture Kick supports potential entrepreneurs with start capital up to CHF 150'000 as well as hands-on execution support and access to a nationwide network of investors and experts in the startup field. Multiple times per year, 8 selected projects get the opportunity to present their business ideas in front of a panel. The 5 most promising projects enter the support process. After 9 months at the latest, the startups incorporate and enter the market. Since 2007, Venture Kick has invested over CHF 58 million in over 1111 projects.
BARD1AG SA
Blood test for cancer detection
Website:
www.bard1.com
EuroGold
Headquarter:
Perth
Foundation Date:
July 2010
Technology:
- Biotech
Sectors:
- Cancer
Support received
